Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Long-Term Deferred Tax (2011 - 2025)

Siga Technologies' (SIGA) quarterly Long-Term Deferred Tax came in at $4.4 million in Q4 2025, down 59.2% on a YoY basis from $10.9 million in Q4 2024, and up 183.8% quarter-over-quarter from $1.6 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Long-Term Deferred Tax (2011 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Long-Term Deferred Tax for 13 consecutive years, with $4.4 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax fell 59.2% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.4 million (down 59.2% YoY), and the FY2025 full-year result was $4.4 million, down 59.2% from the prior year.
  • Long-Term Deferred Tax climbed to $4.4 million in Q4 2025 per SIGA's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $12.1 million in Q3 2024 and bottomed at $1.6 million in Q3 2025.
  • Historically, Long-Term Deferred Tax has averaged $6.4 million across 5 years, with a median of $5.3 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Long-Term Deferred Tax jumped 158.0% in 2022, then plunged 87.11% in 2025.
  • Over 5 years, Long-Term Deferred Tax stood at $2.4 million in 2021, then surged by 158.0% to $6.3 million in 2022, then jumped by 76.76% to $11.0 million in 2023, then slipped by 1.75% to $10.9 million in 2024, then slumped by 59.2% to $4.4 million in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $4.4 million, $1.6 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.43 Mn
Sep 30, 2025 1.56 Mn
Jun 30, 2025 3.97 Mn
Mar 31, 2025 11.13 Mn
Dec 31, 2024 10.85 Mn
Sep 30, 2024 12.10 Mn
Jun 30, 2024 11.61 Mn
Mar 31, 2024 11.01 Mn
Dec 31, 2023 11.05 Mn
Sep 30, 2023 7.90 Mn
Jun 30, 2023 7.59 Mn
Mar 31, 2023 6.73 Mn
Dec 31, 2022 6.25 Mn
Sep 30, 2022 4.18 Mn
Jun 30, 2022 3.04 Mn
Mar 31, 2022 4.04 Mn
Dec 31, 2021 2.42 Mn
Sep 30, 2021 2.95 Mn
Jun 30, 2021 2.73 Mn
Mar 31, 2021 2.57 Mn